-
From medical professionals to law enforcement to recovering addicts, the opioid crisis has affected people from all walks of life. At a University of...
-
A few hundred hospitals have banded together to sue drugmakers in state courts, but far more are staying on the sidelines to avoid 'unflattering attention' about their role in the opioid crisis.
-
Four defendants, including three big U.S. distributors, have struck a deal with Summit and Cuyahoga counties. It doesn't resolve thousands of other lawsuits filed against the firms across the U.S.
-
Dr. Joel Smithers was convicted in May of more than 800 federal counts of illegal drug distribution. He was facing life in prison and a $200 million fine. The court ordered him to pay $86,000.
-
The Miami-Dade County School Board has filed a federal lawsuit against more than a dozen corporations that manufacture or distribute opioids, claiming…
-
"The Sackler family does not belong in bankruptcy court," Rep. Max Rose said of Purdue Pharma's owners. "They belong in handcuffs." He and others want charges for drug companies linked to the crisis.
-
The Sackler family, owner of OxyContin-maker Purdue Pharma, is behind the recent $6.8 million purchase of a rehabbed downtown West Palm Beach office…
-
The bankruptcy follows the Sackler family, which owns Purdue, agreeing to surrender control of the company and offering $3 billion in cash to opioid-hit communities.
-
The pending settlement likely means Purdue will avoid going to trial in the sprawling and complicated case involving some 2,300 local governments across 23 states.
-
A group of state attorneys general negotiating with members of the Sackler family says they expect Purdue Pharma to file for bankruptcy "imminently," according to an email obtained by NPR.
-
Purdue Pharma, Johnson & Johnson and other health care giants are discussing potential deals with authorities that could resolve thousands of lawsuits they're facing over the U.S. opioid epidemic.
-
In a landmark ruling, Judge Thad Balkman ruled in favor of Oklahoma in its lawsuit to hold the drugmaker accountable for the costs of opioid addiction in the state.